SUNPHARMA delivered a strong weekly performance with a 3.18% return, outperforming peers DRREDDY and HINDUNILVR, but falling short of its volatility-adjusted return compared to DRREDDY. The stock's volatility was moderate at 8.74%, lower than DIVISLAB and HINDUNILVR, but higher than DRREDDY. With a Sharpe Ratio of 1.43, SUNPHARMA's return was relatively risk-efficient. Overall, the stock's performance was robust, but not exceptionally risky this week.

[Volatility: 8.74%]